Immunomodulation Therapy – Clinical Relevance of Bacterial Lysates OM-85
Authors:
- Giovanni A RossiGiovanni A Rossi
- Susanna EspositoSESusanna Esposito
- Wojciech FeleszkoWFWojciech Feleszko
- Giovanni MelioliGMGiovanni Melioli
- Dario OlivieriDODario Olivieri
- Giorgio PiacentiniGPGiorgio Piacentini
- Francesco ScaglioneFSFrancesco Scaglione
- Donata VercelliDVDonata Vercelli
Open Access
- 1 January 2019
- journal article
- Published by Touch Medical Media, Ltd. in European Respiratory & Pulmonary Diseases
- Vol. 5 (1)
Abstract
Respiratory tract infections (RTIs) affect children and adults with chronic respiratory conditions throughout the world. As RTIs can often recur, they confer a significant morbidity and mortality burden and represent an important unmet medical need. Studies have shown that the bacterial lysates OM-85 can activate both innate and adaptive immune responses via maturation of gut mucosal dendritic cells, resulting in the homing of immune cells to lymphoid tissue in the lungs and subsequent antibody production.Keywords
Funding Information
- This article is published under the Creative Commons Attribution Non-commercial License.
This publication has 47 references indexed in Scilit:
- Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidenceCurrent Opinion in Allergy and Clinical Immunology, 2018
- Diagnosis and Management of Recurrent Respiratory Tract Infections in Children: A Practical GuideArchives of Pediatric Infectious Diseases, 2015
- Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children*Pediatric Critical Care Medicine, 2015
- Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthmaAnnals of Allergy, Asthma & Immunology, 2015
- Recent Trends in Outpatient Antibiotic Use in ChildrenPediatrics, 2014
- Viral and Bacterial Interactions in the Upper Respiratory TractPLOS Pathogens, 2013
- Prevalence and Clinical Course of Viral Upper Respiratory Tract Infections in Immunocompromised Pediatric Patients With Malignancies or After Hematopoietic Stem Cell TransplantationJournal of Pediatric Hematology/Oncology, 2012
- Modifiable risk factors for acute lower respiratory tract infectionsIndian Journal of Pediatrics, 2007
- NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from FinlandEuropean Heart Journal, 2006
- Electrophysiological effects of labetolol on rabbit atrial, ventricular and Purkinje cells, in normoxia and hypoxiaCardiovascular Research, 1982